Mr Ravi Mehrotra has held the position of Executive Chairman and Executive Director of RHT TM since 7 September 2012.
Mr Mehrotra has experience spanning over 30 years in the financial services sector both within India and internationally. He has with him, extensive experience in fund management in the areas of investment and corporate banking as well as equities. Prior to his appointment at RHT TM, he held various key positions in PineBridge Investments, Hong Kong (previously AIG Investments). He served as Managing Director and Global Head of Retail & Intermediary Channels at PineBridge Investments as well as Global Head of Retail & Intermediary Channels at AIG Investments. As Managing Director and Regional Head, he was responsible for overseeing asset management companies in China, India, the Philippines and Taiwan. In addition, he had previously been the President and Chief Investment Officer (Equities) at Franklin Templeton Asset Management (India) as well as the Senior Vice President and Chief Investment Officer at Kothari Pioneer Asset Management. At Bank of America in India, Mr Mehrotra was a Vice President in the Investment Banking and Treasury Group. Mr Mehrotra currently also sits on the Board of FHL, the Sponsor of RHT.
Mr Mehrotra graduated from the University of Mumbai with a Bachelor of Commerce. He also received a Post Graduate Diploma in Business Management from the Xavier Labour Relations Institute of Jamshedpur in India.
Mr Gurpreet Singh Dhillon is the Chief Executive Officer and Executive Director of RHT TM where he oversees all key operations and business development plans of RHT. Mr Dhillon currently serves as a Director on the Board of Fortis Global Healthcare Infrastructure Pte. Ltd. and Religare Healthtrust Services Pte. Ltd., both of which are wholly-owned subsidiaries of RHT.
Mr Dhillon is experienced in the fields of asset management and investments. He had played key advisory roles in real estate acquisitions across India and the United Kingdom during his career in Religare Capital Markets, Plc, the investment banking arm of Religare Enterprises Limited before he joined RHT TM. Mr Dhillon joined the Trustee-Manager as Chief Operating Officer before he was appointed the Chief Executive Officer.
Mr Dhillon graduated from the University of Essex with a Bachelor of Law degree.
Appointed as Chief Financial Officer ("CFO") and Executive Director since 1 January 2013, Mr Pawanpreet Singh has experience in accounting and finance.
Prior to his appointment as CFO of RHT TM, Mr Singh spent most his career working in the healthcare sector in India. Between 2005 and 2011, Mr Singh held the position of Corporate Controller of Finance in Fortis Healthcare Limited where he played a key role in its IPO Offering, rights- and issuance of convertible bonds. He was also the CFO of Super Religare Laboratories Limited where he played an active role in its business development plans.
Mr Singh holds a Bachelor of Commerce (Honours) degree from Punjab University, Chandigarh. He is currently a member of the Institute of Chartered Accountants of India as well as the Institute of Costs & Works Accountants of India.
Dr Yogendra Nath Mathur joined the the Board of the Trustee-Manager as Lead Independent Director on 7 September 2012.
Prior to his appointment, Dr Mathur spent a large part of his career with the United Nations Children's Fund ("UNICEF"), where he held key positions and memberships in several government bodies. He was actively involved in social development and welfare initiatives, particularly for women and children. Dr Mathur was a member of the Central Review Board. As Project Officer (Health and Nutrition) with the UNICEF, he had helped establish an immunization programme. He was also Chief of State Office for Andhra Pradesh, Karnataka and Gujarat. He was appointed Head of the Regional Medical Research Centre for Tribal Health in Jabalpur, Madhya Pradesh prior to his work at UNICEF.
Dr Mathur holds a Bachelor of Medicine and a Bachelor of Surgery from Nagpur University. In addition, he received a Doctorate of Medicine (Preventive and Social Medicine) from the All-India Institute of Medical Sciences, New Delhi. Dr Mathur is currently the Secretary of the Maharaj Jagat Singh Medical Relief Society and RSSB Education & Environment Society.
Mr Peter Joseph Seymour Rowe sits on the Board of the Trustee Manager and is also the Chairman of the Audit and Risk Management Committee.
Mr Rowe brings with him over 35 years of experience in the financial services industry, particularly in the areas of fund management and compliance. He is currently a consultant at Herbert Smith Freehills ("HSF") where he had previously been made a Partner and was also appointed Head of the Financial Services Group. Apart from the Board of RHT TM, Mr Rowe sits on the Board of other real estate management related companies in Australia as well as his appointment as Chairman for AMP Capital.
Mr Rowe received a Diploma in Law from the Solicitors Admission Board of New South Wales, Australia.
Mr Eng Meng Leong is an Independent Director and serves on the Board of RHT TM as Chairman of the Remuneration Committee. He currently holds directorship on the Board of a public listed company, Croesus Retail Asset Management Pte. Ltd. Mr Eng brings with him expertise, spanning over 25 years, in the fields of taxation in Singapore and internationally.
Prior to his appointment with RHT TM since 2013, Mr Eng was the Director of Tax Services and Head of Financial Services in KPMG Tax Services Pte. Ltd. During his stint with KPMG, he played a key role in taxation works in relation to M&As, IPOs, compliance and corporate finance matters.
Mr Eng is currently a member of the Institute of Certified Public Accountants of Singapore and an accredited Tax Advisor of the Singapore Institute of Accredited Tax Professionals. He was also admitted as a member of the Institute of Chartered Accountants of England and Wales in 1982.
Mr Sydney Michael Hwang is an Independent Director and also Chairman of the Nominating Committee. Mr Hwang practices as an independent barrister, international arbitrator and is the Chief Justice of the Dubai International Financial Centre Courts.
Mr Hwang was formerly a Judicial Commissioner of the Supreme Court of Singapore and was also one of the first 12 Senior Counsel appointed in Singapore. His previous appointments include Partner and Head of Litigation and Arbitration at Allen & Gledhill, Commissioner of the UN Compensation Commission on compensation payable by Iraq in respect of the First Gulf War, and President of the Law Society of Singapore.
Mr Hwang currently also sits on the Boards of various companies such as Linyi Investments Private Limited, Singapore Dance Theatre Limited, YTL Starhill Global REIT Management Limited, Memories of the East Pte. Ltd., Justinian Private Limited and is the Sole Director of Michael Hwang Chambers LLC.
Mr Hwang holds an undergraduate and post graduate law degree from Oxford University and an Honorary Doctor of Laws degree from the University of Sydney. He is currently on the advisory or consultative boards of the Singapore International Arbitration Centre and the Hong Kong International Arbitration Centre and the Swiss Arbitration Association.